Protara Therapeutics, Inc. (TARA)
NASDAQ$4.31
Market Cap
$158.47M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
868 of 924
Rank in Industry
494 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
TARA Insider Trading Activity
TARA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,750,190 | 19 | 100 |
Related Transactions
| Opaleye Management Inc. | 10 percent owner | 0 | $0 | 19 | $1.75M | $-1.75M |
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed …
Insider Activity of Protara Therapeutics, Inc.
Over the last 12 months, insiders at Protara Therapeutics, Inc. have bought $0 and sold $1.75M worth of Protara Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Protara Therapeutics, Inc. have bought $2.31M and sold $1.19M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 9,065 shares for transaction amount of $34,810 was made by Shefferman Jesse (CEO and President) on 2022‑08‑11.
List of Insider Buy and Sell Transactions, Protara Therapeutics, Inc.
| 2024-09-12 | Sale | Opaleye Management Inc. | 10 percent owner | 126,301 0.6048% | $1.71 | $215,836 | +104.62% | |
| 2024-09-11 | Sale | Opaleye Management Inc. | 10 percent owner | 32,600 0.1566% | $1.71 | $55,880 | +107.65% | |
| 2024-09-10 | Sale | Opaleye Management Inc. | 10 percent owner | 25,500 0.1264% | $1.77 | $45,110 | +103.47% | |
| 2024-09-09 | Sale | Opaleye Management Inc. | 10 percent owner | 36,492 0.1821% | $1.89 | $69,141 | +89.54% | |
| 2024-07-16 | Sale | Opaleye Management Inc. | 10 percent owner | 11,396 0.0691% | $2.44 | $27,828 | +3.75% | |
| 2024-07-11 | Sale | Opaleye Management Inc. | 10 percent owner | 47,993 0.2866% | $2.40 | $115,346 | +5.56% | |
| 2024-07-10 | Sale | Opaleye Management Inc. | 10 percent owner | 18,061 0.1036% | $2.31 | $41,685 | +6.49% | |
| 2024-07-09 | Sale | Opaleye Management Inc. | 10 percent owner | 8,497 0.0467% | $2.21 | $18,811 | +15.02% | |
| 2024-07-01 | Sale | Opaleye Management Inc. | 10 percent owner | 8,288 0.0437% | $2.12 | $17,598 | +14.59% | |
| 2024-06-28 | Sale | Opaleye Management Inc. | 10 percent owner | 17,994 0.0927% | $2.07 | $37,334 | +14.90% | |
| 2024-06-27 | Sale | Opaleye Management Inc. | 10 percent owner | 46,574 0.2613% | $2.26 | $105,169 | +10.14% | |
| 2024-06-25 | Sale | Opaleye Management Inc. | 10 percent owner | 12,725 0.0665% | $2.26 | $28,734 | +13.57% | |
| 2024-05-31 | Sale | Opaleye Management Inc. | 10 percent owner | 5,824 0.0292% | $2.90 | $16,895 | -14.41% | |
| 2024-05-30 | Sale | Opaleye Management Inc. | 10 percent owner | 9,230 0.0454% | $2.94 | $27,113 | -16.90% | |
| 2024-05-22 | Sale | Opaleye Management Inc. | 10 percent owner | 9,800 0.0481% | $3.02 | $29,596 | -17.39% | |
| 2024-05-21 | Sale | Opaleye Management Inc. | 10 percent owner | 33,000 0.1671% | $3.06 | $100,838 | -15.70% | |
| 2024-05-17 | Sale | Opaleye Management Inc. | 10 percent owner | 70,885 0.3032% | $3.25 | $230,326 | -18.77% | |
| 2024-05-10 | Sale | Opaleye Management Inc. | 10 percent owner | 151,700 0.7648% | $3.11 | $472,424 | -15.33% | |
| 2024-05-09 | Sale | Opaleye Management Inc. | 10 percent owner | 30,600 0.1541% | $3.09 | $94,526 | -14.77% | |
| 2022-12-30 | Sale | Opaleye Management Inc. | director | 15,473 0.1389% | $2.71 | $41,949 | -0.19% |
Total: 91
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Opaleye Management Inc. | 10 percent owner | 45000 0.1224% | $193,950.00 | 15 | 20 | <0.0001% |
| O'Leary Brendan | director | 1387198 3.7729% | $5.98M | 1 | 0 | |
| Abingworth LLP | 10 percent owner | 950000 2.5838% | $4.09M | 1 | 0 | |
| Haines Timothy | 950000 2.5838% | $4.09M | 1 | 0 | ||
| Shefferman Jesse | CEO and President | 879441 2.3919% | $3.79M | 1 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$2,924,567 | 72 | -4.87% | $157.74M | |
$35,190,048 | 32 | 37.32% | $150.49M | |
$79,019,806 | 27 | 7.24% | $165.26M | |
Protara Therapeutics, Inc. (TARA) | $6,915,275 | 21 | -32.61% | $158.47M |
$2,484,989 | 17 | -17.86% | $156.9M |
TARA Institutional Investors: Active Positions
| Increased Positions | 47 | +138.24% | 22M | +207.1% |
| Decreased Positions | 15 | -44.12% | 1M | -12.4% |
| New Positions | 32 | New | 17M | New |
| Sold Out Positions | 5 | Sold Out | 257,442 | Sold Out |
| Total Postitions | 66 | +94.12% | 31M | +194.7% |
TARA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Ra Capital Management, L.P. | $12,716.00 | 10% | 3.4M | +2M | +78.95% | 2024-12-31 |
| Janus Henderson Group Plc | $8,497.00 | 6.68% | 2.27M | +2M | New | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $8,415.00 | 6.62% | 2.25M | +2M | New | 2024-12-31 |
| Toronto Dominion Bank | $7,813.00 | 6.14% | 2.09M | +2M | New | 2024-12-31 |
| Opaleye Management Inc. | $6,826.00 | 5.37% | 1.82M | +143,846 | +8.56% | 2024-12-31 |
| Blackstone Inc. | $6,283.00 | 4.94% | 1.68M | +2M | New | 2024-12-31 |
| Velan Capital Investment Management Lp | $5,905.00 | 4.64% | 1.58M | +1M | +175.09% | 2024-12-31 |
| Sio Capital Management, Llc | $5,376.00 | 4.23% | 1.44M | +1M | New | 2024-12-31 |
| Integral Health Asset Management, Llc | $5,236.00 | 4.12% | 1.4M | +1M | New | 2024-12-31 |
| Vanguard Group Inc | $5,085.00 | 4% | 1.36M | +599,897 | +78.97% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.